Treatment and prognosis of diffuse sclerosing osteomyelitis (DSO) of the mandible.
Twenty-one patients with diffuse sclerosing osteomyelitis (DSO) of the mandible were investigated and treated in Göteborg. Sixteen of these patients ( twelve women and four men) participated in a long-term follow-up study in order to evaluate different therapeutic procedures. Cortisone was found to be a valuable aid to the therapy arsenal. Clinical and radiographic observations are presented. Etiology, therapy, and prognosis of DSO are discussed.
D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002648:Child; D003348:Cortisone / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008336:Mandibular Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D008875:Middle Aged; D010019:Osteomyelitis / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D011379:Prognosis; D011859:Radiography; D012598:Sclerosis
D000900:Anti-Bacterial Agents; D003348:Cortisone